荣昌生物：关于作废部分2022年A股限制性股票激励计划已授予尚未归属的限制性股票的公告

Group 1 - The company announced the decision to annul part of the 2022 A-share restricted stock incentive plan that had been granted but not yet vested [2] - The resolution was passed during the 30th meeting of the second board of directors held on November 4, 2025 [2] - This action reflects the company's strategic adjustments regarding its employee incentive programs [2] Group 2 - The announcement was made public through a formal notice, indicating transparency in corporate governance [2] - The decision may impact the company's future employee retention and motivation strategies [2] - The move is part of broader trends in the industry regarding stock-based compensation adjustments [2]